Both in Surgical Instruments
Daxor vs SkinHealth Systems
Over the past year DXR returned −34.0% and SKIN returned −60.0%; their daily moves had a correlation of 0.03.
DXR −34.0% SKIN −60.0%Growth of $1, one year, split-adjusted
| Metric | DXR | SKIN |
|---|---|---|
| Price | $8.91 | $11.05 |
| Market cap | $52.0M | $72.0M |
| Today | +2.44% | +6.76% |
| 1 month | −13.5% | −5.7% |
| 6 months | −12.1% | −40.8% |
| Year to date | −39.6% | −60.3% |
| 1 year | — | −59.7% |
| Revenue growth (YoY) | +2.3% | −7.8% |
| Gross margin | 52.2% | 68.4% |
| Net margin | −403.2% | −3.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.2× |
| Net cash | $18.7M | -$139.1M |
| Dividend yield | — | — |
| Volatility (60d) | 43.0% | 865.5% |
| Short % of float | 0.1% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).